These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 723406)

  • 21. [Treatment of Ménière's disease with intratympanically applied gentamycin sulphate (author's transl)].
    Katzke D
    Laryngol Rhinol Otol (Stuttg); 1982 Jan; 61(1):4-8. PubMed ID: 7098690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug information. Therapy in Ménière's disease, with special reference to the use of betahistine, Betaserc].
    Pedersen CB; Kampmann JP
    Ugeskr Laeger; 1978 Nov; 140(48):3004-6. PubMed ID: 726109
    [No Abstract]   [Full Text] [Related]  

  • 23. [Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].
    Jurkiewicz D; Kantor I; Usowski J
    Pol Merkur Lekarski; 2006; 21 Suppl 1():3-12. PubMed ID: 17469244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Betahistine in Ménière's disease.
    Wilmot TJ; Menon GN
    J Laryngol Otol; 1976 Sep; 90(9):833-40. PubMed ID: 787460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Initial findings in the treatment of Meniere's disease with betahistine hydrochloride (Betaserc)].
    Segers JM
    Acta Otorhinolaryngol Belg; 1972; 26(2):262-8. PubMed ID: 4626970
    [No Abstract]   [Full Text] [Related]  

  • 26. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of Meniere's disease using betahistine].
    Chüden HG
    Med Welt; 1978 Dec; 29(48):1901-3. PubMed ID: 713816
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug information. Therapeutic main group: agents for the treatment of vertigo. Behahistine (Betaserc)].
    Lumholtz IB
    Sygeplejersken; 1979 Apr; 79(14):19. PubMed ID: 256278
    [No Abstract]   [Full Text] [Related]  

  • 29. [The indications for middle ear instillation of gentamicin in Menière's disease (author's transl)].
    Lange G
    HNO; 1981 Feb; 29(2):49-51. PubMed ID: 7204113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ménière's vertigo. IV. Statistical analysis of the use and effectiveness of drugs in the treatment of endolymphatic hydrops].
    Elorza Arizmendi JF; Bartual Pastor J
    An Otorrinolaringol Ibero Am; 1983; 10(2):139-52. PubMed ID: 6881489
    [No Abstract]   [Full Text] [Related]  

  • 31. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study.
    Oosterveld WJ
    J Laryngol Otol; 1984 Jan; 98(1):37-41. PubMed ID: 6363584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic considerations of Meniere's disease].
    Romeo A
    Ann Laringol Otol Rinol Faringol; 1975; 74(5):435-7. PubMed ID: 1244170
    [No Abstract]   [Full Text] [Related]  

  • 34. [Picrotoxin in the treatment of Menière's disease].
    Weikert S; Rotter A; Scherer H; Hölzl M
    Laryngorhinootologie; 2008 Dec; 87(12):862-6. PubMed ID: 18720328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
    Fattori B; De Iaco G; Nacci A; Casani A; Ursino F
    Undersea Hyperb Med; 2002; 29(4):260-70. PubMed ID: 12797667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effect of betahistine in Meniere's disease by double-blind test and multivariate analysis].
    Watanabe K; Fukami J; Yoshimoto H; Ueda M; Suzuki J
    Jibiinkoka; 1967 Nov; 39(11):1237-50. PubMed ID: 4969849
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of peripheral vestibular vertigo with betahistine dimesilate (Aequamen)].
    Reker U
    MMW Munch Med Wochenschr; 1983 Oct; 125(41):915-8. PubMed ID: 6417495
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute vestibular vertigo.
    Aantaa E
    Acta Otolaryngol Suppl; 1991; 479():44-7. PubMed ID: 2068940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.